Dr. Beau Ances has been making significant contributions to neurodegenerative disease research for more than 20 years, with a particular focus on Alzheimer's disease (AD). In an exclusive interview with MDLinx, Dr. Ances discusses recent advancements in diagnosing AD, including imaging techniques, cerebrospinal fluid analysis, and detecting the presence of amyloid and tau biomarkers. These advancements are also helping to evaluate effectiveness and side effects of new and established therapies while highlighting the importance of early detection.